A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
/in Cervical Cancer, Hyperthermia, International Publications /von 2016-08-14 / Int J Hyperthermia 2016 11;32(7):809-21A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-8Artikel von Prof Schirrmacher in Biomedicines: „Fifty Years of Clinical Application of Newcastle Disease Virus“
/in IOZK Meldungen, IOZK Veröffentlichungen /von IOZKAdvances and challenges: dendritic cell vaccination strategies for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-08-10 / Expert Rev Vaccines 2017 01;16(1):27-36
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution